HEADER TRANSFERASE/TRANSFERASE INHIBITOR 21-MAR-12 4E9D TITLE THE STRUCTURE OF THE POLO-BOX DOMAIN (PBD) OF POLO-LIKE KINASE 1 TITLE 2 (PLK1) IN COMPLEX WITH 3-(1-BENZOTHIOPHEN-2-YL)PROPANOYL-DERIVATIZED TITLE 3 DPPLHSPTA PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PLK1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: POLO-LIKE KINASE 1, PLK-1, SERINE/THREONINE-PROTEIN KINASE COMPND 5 13, STPK13; COMPND 6 EC: 2.7.11.21; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: 3-(1-BENZOTHIOPHEN-2-YL)PROPANOYL-DERIVATIZED DPPLHSPTA COMPND 10 PEPTIDE; COMPND 11 CHAIN: E; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PLK1, PLK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 OTHER_DETAILS: SOLID PHASE PEPTIDE SYNTHESIS KEYWDS SERINE/THREONINE KINASE, TRANSFERASE, PHOSPHOPROTEIN BINDING DOMAIN, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.SLEDZ,M.HYVONEN,S.LANG,C.J.STUBBS,C.ABELL REVDAT 2 17-OCT-12 4E9D 1 JRNL REVDAT 1 10-OCT-12 4E9D 0 JRNL AUTH S.LANG,C.J.STUBBS,C.ABELL JRNL TITL HIGH-THROUGHPUT INTERROGATION OF LIGAND BINDING MODE USING A JRNL TITL 2 FLUORESCENCE-BASED ASSAY. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 51 7680 2012 JRNL REFN ISSN 1433-7851 JRNL PMID 22730171 JRNL DOI 10.1002/ANIE.201202660 REMARK 2 REMARK 2 RESOLUTION. 2.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.29 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 5084 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.270 REMARK 3 R VALUE (WORKING SET) : 0.267 REMARK 3 FREE R VALUE : 0.330 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 246 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.82 REMARK 3 REFLECTION IN BIN (WORKING SET) : 371 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.12 REMARK 3 BIN R VALUE (WORKING SET) : 0.4140 REMARK 3 BIN FREE R VALUE SET COUNT : 19 REMARK 3 BIN FREE R VALUE : 0.4250 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1833 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 6 REMARK 3 SOLVENT ATOMS : 32 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.570 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.849 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.751 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1881 ; 0.026 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2557 ; 2.765 ; 1.994 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 226 ; 4.980 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 82 ;34.125 ;23.293 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 309 ;16.286 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;11.497 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 287 ; 0.173 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1399 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1143 ; 0.446 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1832 ; 0.249 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 738 ; 0.285 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 714 ; 0.502 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4E9D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-MAR-12. REMARK 100 THE RCSB ID CODE IS RCSB071333. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-11 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : BRUKER AXS MICROSTAR REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRUKER PLATINUM 135 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : PROTEUM REMARK 200 DATA SCALING SOFTWARE : PROTEUM REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5422 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.750 REMARK 200 RESOLUTION RANGE LOW (A) : 46.290 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: 3P2Z REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE, 1.0 M LICL, 30% REMARK 280 PEG 6000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE 3-(1-BENZOTHIOPHEN-2-YL)PROPANOYL-DERIVATIZED DPPLHSPTA PEPTIDE REMARK 400 IS PEPTIDE-LIKE, A MEMBER OF ENZYME INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: 3-(1-BENZOTHIOPHEN-2-YL)PROPANOYL-DERIVATIZED DPPLHSPTA REMARK 400 PEPTIDE REMARK 400 CHAIN: E REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 363 REMARK 465 PRO A 364 REMARK 465 LEU A 365 REMARK 465 GLY A 366 REMARK 465 SER A 367 REMARK 465 PRO A 368 REMARK 465 GLU A 369 REMARK 465 PHE A 370 REMARK 465 ASP A 371 REMARK 465 CYS A 372 REMARK 465 NH2 E 10 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 398 CG CD OE1 OE2 REMARK 470 ARG A 456 CG CD NE CZ NH1 NH2 REMARK 470 SER A 467 OG REMARK 470 HIS A 468 CG ND1 CD2 CE1 NE2 REMARK 470 ASN A 470 CG OD1 ND2 REMARK 470 LYS A 474 CD CE NZ REMARK 470 GLU A 504 CG CD OE1 OE2 REMARK 470 ARG A 507 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 512 NE CZ NH1 NH2 REMARK 470 ARG A 518 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 556 CG CD CE NZ REMARK 470 LYS A 574 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR A 417 CE2 TYR A 417 CD2 -0.092 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 416 CB - CG - OD1 ANGL. DEV. = 6.4 DEGREES REMARK 500 PRO E 3 C - N - CA ANGL. DEV. = 9.0 DEGREES REMARK 500 PRO E 3 O - C - N ANGL. DEV. = 16.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 388 78.58 54.43 REMARK 500 ASP A 402 86.22 -157.84 REMARK 500 TYR A 417 37.11 -146.26 REMARK 500 LYS A 420 -49.01 -143.49 REMARK 500 ASN A 430 -0.91 70.99 REMARK 500 ASP A 449 -37.62 -141.46 REMARK 500 ARG A 456 43.09 -81.67 REMARK 500 ASP A 457 -7.27 -162.74 REMARK 500 ALA A 548 79.88 45.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 719 DISTANCE = 5.45 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF 3-(1-BENZOTHIOPHEN- REMARK 800 2-YL)PROPANOYL-DERIVATIZED DPPLHSPTA PEPTIDE REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4E9C RELATED DB: PDB REMARK 900 RELATED ID: 4E67 RELATED DB: PDB DBREF 4E9D A 371 594 UNP P53350 PLK1_HUMAN 371 594 DBREF 4E9D E 1 10 PDB 4E9D 4E9D 1 10 SEQADV 4E9D GLY A 363 UNP P53350 EXPRESSION TAG SEQADV 4E9D PRO A 364 UNP P53350 EXPRESSION TAG SEQADV 4E9D LEU A 365 UNP P53350 EXPRESSION TAG SEQADV 4E9D GLY A 366 UNP P53350 EXPRESSION TAG SEQADV 4E9D SER A 367 UNP P53350 EXPRESSION TAG SEQADV 4E9D PRO A 368 UNP P53350 EXPRESSION TAG SEQADV 4E9D GLU A 369 UNP P53350 EXPRESSION TAG SEQADV 4E9D PHE A 370 UNP P53350 EXPRESSION TAG SEQRES 1 A 232 GLY PRO LEU GLY SER PRO GLU PHE ASP CYS HIS LEU SER SEQRES 2 A 232 ASP MET LEU GLN GLN LEU HIS SER VAL ASN ALA SER LYS SEQRES 3 A 232 PRO SER GLU ARG GLY LEU VAL ARG GLN GLU GLU ALA GLU SEQRES 4 A 232 ASP PRO ALA CYS ILE PRO ILE PHE TRP VAL SER LYS TRP SEQRES 5 A 232 VAL ASP TYR SER ASP LYS TYR GLY LEU GLY TYR GLN LEU SEQRES 6 A 232 CYS ASP ASN SER VAL GLY VAL LEU PHE ASN ASP SER THR SEQRES 7 A 232 ARG LEU ILE LEU TYR ASN ASP GLY ASP SER LEU GLN TYR SEQRES 8 A 232 ILE GLU ARG ASP GLY THR GLU SER TYR LEU THR VAL SER SEQRES 9 A 232 SER HIS PRO ASN SER LEU MET LYS LYS ILE THR LEU LEU SEQRES 10 A 232 LYS TYR PHE ARG ASN TYR MET SER GLU HIS LEU LEU LYS SEQRES 11 A 232 ALA GLY ALA ASN ILE THR PRO ARG GLU GLY ASP GLU LEU SEQRES 12 A 232 ALA ARG LEU PRO TYR LEU ARG THR TRP PHE ARG THR ARG SEQRES 13 A 232 SER ALA ILE ILE LEU HIS LEU SER ASN GLY SER VAL GLN SEQRES 14 A 232 ILE ASN PHE PHE GLN ASP HIS THR LYS LEU ILE LEU CYS SEQRES 15 A 232 PRO LEU MET ALA ALA VAL THR TYR ILE ASP GLU LYS ARG SEQRES 16 A 232 ASP PHE ARG THR TYR ARG LEU SER LEU LEU GLU GLU TYR SEQRES 17 A 232 GLY CYS CYS LYS GLU LEU ALA SER ARG LEU ARG TYR ALA SEQRES 18 A 232 ARG THR MET VAL ASP LYS LEU LEU SER SER ARG SEQRES 1 E 10 0OB ASP PRO PRO LEU HIS SER TPO ALA NH2 MODRES 4E9D TPO E 8 THR PHOSPHOTHREONINE HET 0OB E 1 13 HET TPO E 8 11 HET GOL A 601 6 HETNAM 0OB 3-(1-BENZOTHIOPHEN-2-YL)PROPANOIC ACID HETNAM TPO PHOSPHOTHREONINE HETNAM GOL GLYCEROL HETSYN TPO PHOSPHONOTHREONINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 0OB C11 H10 O2 S FORMUL 2 TPO C4 H10 N O6 P FORMUL 3 GOL C3 H8 O3 FORMUL 4 HOH *32(H2 O) HELIX 1 1 SER A 375 ALA A 386 1 12 HELIX 2 2 ARG A 396 GLU A 401 5 6 HELIX 3 3 ASP A 402 ILE A 406 5 5 HELIX 4 4 LEU A 472 LEU A 490 1 19 HELIX 5 5 LEU A 564 TYR A 570 1 7 HELIX 6 6 CYS A 573 LEU A 591 1 19 SHEET 1 A 4 VAL A 432 PHE A 436 0 SHEET 2 A 4 GLY A 422 LEU A 427 -1 N TYR A 425 O GLY A 433 SHEET 3 A 4 VAL A 411 ASP A 416 -1 N LYS A 413 O GLN A 426 SHEET 4 A 4 LEU E 5 HIS E 6 -1 O LEU E 5 N ASP A 416 SHEET 1 B 3 ARG A 441 LEU A 444 0 SHEET 2 B 3 SER A 450 ILE A 454 -1 O GLN A 452 N ILE A 443 SHEET 3 B 3 GLU A 460 THR A 464 -1 O LEU A 463 N LEU A 451 SHEET 1 C 6 LEU A 511 ARG A 516 0 SHEET 2 C 6 ALA A 520 LEU A 525 -1 O ILE A 522 N PHE A 515 SHEET 3 C 6 VAL A 530 PHE A 534 -1 O GLN A 531 N LEU A 523 SHEET 4 C 6 LYS A 540 CYS A 544 -1 O LEU A 543 N VAL A 530 SHEET 5 C 6 ALA A 549 ILE A 553 -1 O ALA A 549 N CYS A 544 SHEET 6 C 6 PHE A 559 ARG A 563 -1 O ARG A 560 N TYR A 552 LINK C SER E 7 N TPO E 8 1555 1555 1.34 LINK C TPO E 8 N ALA E 9 1555 1555 1.33 LINK CAU 0OB E 1 N ASP E 2 1555 1555 1.30 SITE 1 AC1 1 ARG A 594 SITE 1 AC2 22 ARG A 392 GLY A 393 LYS A 413 TRP A 414 SITE 2 AC2 22 ASP A 416 TYR A 417 ASP A 419 TYR A 421 SITE 3 AC2 22 ASP A 457 GLY A 458 THR A 459 TYR A 481 SITE 4 AC2 22 PHE A 482 TYR A 485 LEU A 490 LEU A 491 SITE 5 AC2 22 ARG A 516 HIS A 538 LYS A 540 GLU A 568 SITE 6 AC2 22 HOH E 101 HOH E 102 CRYST1 35.873 36.302 47.474 85.84 77.21 68.24 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027876 -0.011130 -0.006445 0.00000 SCALE2 0.000000 0.029661 0.000311 0.00000 SCALE3 0.000000 0.000000 0.021601 0.00000